State Board of Administration of Florida Retirement System’s Harvard Bioscience HBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-1,143
Closed -$61.2K 2283
2023
Q4
$61.2K Hold
1,143
﹤0.01% 2312
2023
Q3
$49.1K Buy
1,143
+32
+3% +$1.48K ﹤0.01% 2341
2023
Q2
$61K Buy
+1,111
New +$61K ﹤0.01% 2369

Other funds holding HBIO

State Board of Administration of Florida Retirement System's HBIO Position: Q1 2024 in Review

State Board of Administration of Florida Retirement System sold out of Harvard Bioscience (HBIO) in Q1 2024, closing a stake of 1,143 shares — an estimated $61.2K sold.

State Board of Administration of Florida Retirement System first reported a position in HBIO in Q2 2023 and held it in 3 quarters. The position peaked at $61.2K in Q4 2023. 89 funds tracked by Wall St. Rank hold HBIO as of Q1 2024.

  • State Board of Administration of Florida Retirement System reported no remaining Harvard Bioscience position as of Q1 2024 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 1,143 Harvard Bioscience shares in Q1 2024, an estimated $61.2K.
  • State Board of Administration of Florida Retirement System first reported a position in Harvard Bioscience in Q2 2023 and held it in 3 quarters.
  • State Board of Administration of Florida Retirement System's Harvard Bioscience position peaked at $61.2K in Q4 2023.
  • 89 funds tracked by Wall St. Rank held Harvard Bioscience as of Q1 2024.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q1 2024, filed 8 May 2024.